+5,146.5%
COF vs GSK
+924.9%
+4,221.5%
-90.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.0% | -0.1% | -0.9% | -0.9% |
| 7D | -2.7% | -1.3% | -1.4% | -2.1% |
| 30D | -4.2% | +2.7% | -7.0% | -5.8% |
| 3M | -14.7% | +2.7% | -17.4% | -16.4% |
| 6M | +4.0% | +3.3% | +0.7% | +1.2% |
| YTD | -19.3% | +6.5% | -25.8% | -23.3% |
| 1Y | -7.1% | +10.7% | -17.7% | -13.4% |
| 3Y | +91.6% | +64.4% | +27.3% | +38.0% |
| 5Y | +36.7% | +46.7% | -10.0% | +1.8% |
| 10Y | +185.1% | +109.4% | +75.8% | +71.8% |
| All | +5,146.5% | +924.9% | +4,221.5% | +1,878.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling